Methicillin-Resistant Staphylococcus Aureus (MRSA)Symptoms, Doctors, Treatments, Advances & More
Learn About Methicillin-Resistant Staphylococcus Aureus (MRSA)
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Duke Infectious Diseases Clinic - Clinic 1K
Vance Fowler is an Infectious Disease provider practicing medicine in Durham, North Carolina. He has been practicing medicine for over 33 years. Dr. Fowler is rated as an Elite provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Sepsis, Endocarditis, Methicillin-Resistant Staphylococcus Aureus (MRSA), and Infective Endocarditis. Dr. Fowler is board certified in American Board Of Internal Med, Infectious Diseases.
Medical Education Assistance Corporation
Dima Youssef is an Infectious Disease provider practicing medicine in Johnson City, Tennessee. Dr. Youssef is rated as a Distinguished provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). She is also highly rated in 23 other conditions, according to our data. Her clinical expertise encompasses Sepsis, Endocarditis, Pneumonia, and Cellulitis. Dr. Youssef is board certified in American Board Of Internal Medicine.
MacGregor Infection Medicine And Travel Program
Michael David is an Infectious Disease provider practicing medicine in Philadelphia, Pennsylvania. Dr. David is rated as an Elite provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Methicillin-Resistant Staphylococcus Aureus (MRSA), Sepsis, Osteomyelitis, Osteotomy, and Aneurysm Repair. Dr. David is board certified in Infectious Disease, 2009 and Internal Medicine, 2004. Dr. David is currently accepting new patients.
Summary: Antibacterial prophylaxis is recommended in patients at high risk of infection, specifically patients undergoing acute leukemia induction therapy or hematopoietic stem cell transplant (HSCT) who are expected to have profound neutropenia (ANC\<100 neutrophils/milliliter) for more than seven days. Xerava™ (eravacycline) has a broad spectrum of activity including many multi-drug resistant strains of ...
Summary: This is an open label randomized controlled trial for patients with methicillin resistant S. aureus (MRSA) bloodstream infection which will directly compare the two most commonly used therapies, vancomycin and daptomycin. This study is an approved sub-study of The Staphylococcus aureus Network Adaptive Platform (SNAP) trial (NCT05137119)